| Literature DB >> 34105065 |
J Adam Law1, Laura V Duggan2, Mathieu Asselin3,4, Paul Baker5, Edward Crosby6, Andrew Downey7, Orlando R Hung8, George Kovacs9, François Lemay10, Rudiger Noppens11, Matteo Parotto12,13, Roanne Preston14, Nick Sowers9, Kathryn Sparrow15, Timothy P Turkstra11, David T Wong16, Philip M Jones17.
Abstract
PURPOSE: Since the last Canadian Airway Focus Group (CAFG) guidelines were published in 2013, the published airway management literature has expanded substantially. The CAFG therefore re-convened to examine this literature and update practice recommendations. This second of two articles addresses airway evaluation, decision-making, and safe implementation of an airway management strategy when difficulty is anticipated. SOURCE: Canadian Airway Focus Group members, including anesthesia, emergency medicine, and critical care physicians were assigned topics to search. Searches were run in the Medline, EMBASE, Cochrane Central Register of Controlled Trials, and CINAHL databases. Results were presented to the group and discussed during video conferences every two weeks from April 2018 to July 2020. These CAFG recommendations are based on the best available published evidence. Where high-quality evidence is lacking, statements are based on group consensus. FINDINGS AND KEY RECOMMENDATIONS: Prior to airway management, a documented strategy should be formulated for every patient, based on airway evaluation. Bedside examination should seek predictors of difficulty with face-mask ventilation (FMV), tracheal intubation using video- or direct laryngoscopy (VL or DL), supraglottic airway use, as well as emergency front of neck airway access. Patient physiology and contextual issues should also be assessed. Predicted difficulty should prompt careful decision-making on how most safely to proceed with airway management. Awake tracheal intubation may provide an extra margin of safety when impossible VL or DL is predicted, when difficulty is predicted with more than one mode of airway management (e.g., tracheal intubation and FMV), or when predicted difficulty coincides with significant physiologic or contextual issues. If managing the patient after the induction of general anesthesia despite predicted difficulty, team briefing should include triggers for moving from one technique to the next, expert assistance should be sourced, and required equipment should be present. Unanticipated difficulty with airway management can always occur, so the airway manager should have a strategy for difficulty occurring in every patient, and the institution must make difficult airway equipment readily available. Tracheal extubation of the at-risk patient must also be carefully planned, including assessment of the patient's tolerance for withdrawal of airway support and whether re-intubation might be difficult.Entities:
Keywords: airway management; anticipated; difficult; guidelines; intubation; tracheal
Mesh:
Year: 2021 PMID: 34105065 PMCID: PMC8186352 DOI: 10.1007/s12630-021-02008-z
Source DB: PubMed Journal: Can J Anaesth ISSN: 0832-610X Impact factor: 5.063
Published predictors of difficult tracheal intubation using direct laryngoscopy
• Age > 46 yr • Male sex • Modified Mallampati grades 3 or 4 • Thyromental distance < 6 cm • Prominent, gapped, repaired, or fragile dentition • Limited cervical spine extension • Limited inter-incisor gap • Previous neck radiation • Increased body mass index (conflicting results) • History of obstructive sleep apnea • High upper lip bite test/limited mandibular protrusion • Increased neck circumference • History of difficult direct laryngoscopy or tracheal intubation • Absence of neuromuscular blockade |
Published predictors of difficult tracheal intubation using video laryngoscopy
• Abnormal neck anatomy (e.g., due to pathology, scar, remote radiation); thick neck • Male sex • Large tongue • Thyromental distance < 6 cm • Short sternothyroid distance • Limited cervical spine motion • Limited mouth opening • High upper lip bite test/limited mandibular protrusion • Upper airway soiled by blood or vomitus • Previously obtained high Cormack–Lehane grade during direct laryngoscopy • Surgery type (head and neck or cardiac) • Airway manager inexperience |
Published predictors of difficult tracheal intubation using other devices
• Increased body mass index • Decreased mouth opening • Higher Cormack–Lehane grade |
• Visibility impaired by blood or secretions • Higher neck skinfold thickness • Larger tracheal tube inner diameter relative to scope outer diameter |
Published predictors of difficulty with face-mask ventilation and difficult face-mask ventilation combined with difficult direct laryngoscopy
• Age ≥ 46 yr • Body mass index ≥ 35 kg·m−2 • Male sex • History of snoring • Obstructive sleep apnea • Facial hair • Previous neck radiation • Thick and/or short neck • Absence of teeth • Modified Mallampati class 3 or 4 • Limited mandibular protrusion • History of difficult tracheal intubation • Absence of neuromuscular blockade |
• Age ≥ 46 yr • Body mass index ≥ 30 kg·m−2 • Male sex • Obstructive sleep apnea • Facial hair • Modified Mallampati class 3 or 4 • Decreased thyromental distance (e.g., < 6 cm) • Thick neck; neck mass or previous neck radiation • Presence of teeth • Limited cervical spine mobility • Limited mandibular protrusion. |
Published predictors of difficult supraglottic airway use in the adult patient
• No teeth or poor dentition • Reduced inter-incisor distance • Mallampati 3 or 4 • Limited head/neck mobility • Non-use of neuromuscular blockade • Increased body mass index • Neck circumference • Non-supine patient position • Use of desflurane • Use of smaller size supraglottic airway than recommended • Multiple insertion attempts |
Presumptive predictors of difficulty with front of neck airway access
• Indistinct anatomic landmarks due to obesity, thick or short neck, subcutaneous emphysema, or surgical scarring • Overlying hematoma, induration, inflammation, or tumour • Previous neck radiation • Female sex • Laterally deviated larynx • Limitation to head or neck extension—e.g., fixed flexion deformity |
Physiologic and contextual issues that may impact airway management
• Apnea intolerance, based on: ○ Decreased functional residual capacity ○ Increased oxygen consumption ○ Baseline hypoxemia; decreased PaO2/FiO2 ratio ○ Acid-base disturbance with respiratory compensation. • Full stomach or other major risk factor for aspiration. • Hemodynamic instability. |
• Adverse location (e.g., remote location, difficult access to patient, adverse lighting conditions) • Help/backup unavailable (e.g., because of time of day or remote location) • Airway manager inexperience with chosen or required technique • Lack of equipment • Team inexperienced with difficult airway management • Poor team communication |
Fig. 1Flow diagram: Decision-making when difficult tracheal intubation is predicted. ATI = awake tracheal intubation; DL = direct laryngoscopy; FMV = face-mask ventilation; SGA = supraglottic airway; VL = video laryngoscopy.
Components of the “double set-up” in airway management
• Mark the location of the cricothyroid membrane with the patient’s head and neck extended. Use ultrasound guidance if skilled. • Decide who will undertake eFONA. This should be someone other than the primary airway manager if possible. • Ensure equipment for the chosen eFONA technique is present in the room, opened, and ready to use. • Brief the team before induction, including the potential need for eFONA and triggers for proceeding with it. |
• The double set-up will help focus everyone’s attention on the anticipated airway management difficulty and patient risk. • Equipment and personnel are present in the room while the airway is being secured. • eFONA will be perceived as part of the plan, rather than the rescue of a failed plan. Timelier onset of eFONA may result. |
eFONA = emergency front of neck airway access.
Benefits of and limitations to the use of VL and FB for facilitating awake tracheal intubation
• Enables a broad view of anatomy and good spatial awareness; facilitates a shared mental model with other team members. • The tracheal tube can be directed to and observed to pass between the vocal cords. • The “pink-out” that can occur if a FB abuts mucosa is avoided. • Variously sized styleted tracheal tubes can be prepared; it is easier to substitute a smaller sized tracheal tube than re-load and re-insert a FB if the initial tube size is too large. • Space is created in the oropharynx with gentle lifting of the blade during VL. • As a familiar technique, VL may allow more rapid ATI than the FB. • VL may not be an option with some anatomic and pathologic abnormalities (e.g., very limited mouth opening, fixed neck flexion deformity, enlarged tongue, or base of tongue masses). |
• Passage of the FB and tracheal tube can occur by the nasal route, if necessary. • Navigation is possible in all planes around obstructing masses (e.g., a base of tongue lesion). • Advanced to just above the carina, the FB acts as a guide for tracheal tube advancement to, through, and beyond the larynx. The FB can also be used to confirm successful tracheal intubation and can be used to ensure correct tube positioning above the carina. • The FB can be used for some situations where anatomic constraints preclude use of awake VL. Thus, airway managers must also attain and maintain skills with the FB for ATI. • Using the FB routinely for ATI maintains skills in a critical technique. • Permits examination of the trachea to rule out injury, or to ensure a tracheal tube is placed distal to a known or suspected penetrating tracheal injury or fistula. |
ATI = awake tracheal intubation; FB = flexible bronchoscope; VL = video laryngoscopy.
Airway management considerations for the patient with known or suspected respiratory infectious disease spread by droplet or aerosol
• If out of the operating room/theatre, an airborne infection isolation room is preferred for tracheal intubation. • A negative pressure environment is preferred regardless of location, but ventilation rate/air exchanges are more important than positive or negative pressurization. • Minimize team members in the room. The most experienced available airway manager should perform tracheal intubation. • Supervised personal protective equipment (PPE) donning should occur. • Perform team briefing; use a checklist. • Simulation-based team training is valuable. | |
• Place a viral filter between tracheal tube, face mask, or supraglottic airway (SGA) and more proximal ventilation equipment. • Sidestream capnography aspiration to be located proximal to the viral filter. • Use video laryngoscopy as primary technique: ○ To increase first-pass success ○ To avoid close proximity to patient’s face and respiratory tract ○ To enable a shared mental model and situation awareness of non-intubating team members. • Consider using SGAs for airway rescue scenarios only—not as a planned technique. Second-generation devices are recommended for their higher seal pressures. • Take pre-packaged kits with required equipment into the room. • Position a standby airway cart (+/− additional personnel in PPE as “runners”) outside room. | |
• Pre-oxygenate with a well-applied face mask. • Add PEEP valve to bag-valve mask set-up, if using. • Limit flow rates to the least required to obtain desired fraction of exhaled oxygen value (e.g., 0.9). This may not always be achievable. | |
• Intravenous induction with NMB preferred. • FMV discouraged while awaiting onset of NMB unless clinically significant hypoxemia has occurred or is expected. • Avoid apneic oxygenation with HFNO. • If apneic oxygenation is used, consider use of low oxygen flows (e.g., 5 L min−1). | |
• Most experienced airway manager available should manage the airway. • Ensure a styleted tracheal tube or bougie is available, as appropriate to the video laryngoscope blade in use. • Institute positive pressure ventilation only after tracheal tube cuff inflation. • If high airway pressures are encountered, ensure tracheal tube cuff pressure is 5 cm H20 higher than peak inspiratory pressure. | |
• Use FMV between intubation attempts only if needed to re-oxygenate the patient. • If FMV is undertaken, use two-handed mask application with thenar eminence (“V-E”) grip to maximize seal and jaw lift effectiveness. • Use waveform capnography to confirm efficacy of rescue ventilation. • Avoid excessive ventilation. Respiratory rate, volume and inspiratory pressure should ideally be guided by objective feedback (waveform capnography, pressure manometer). • For the elective surgical patient, if SGA rescue is used, consider using a second-generation device that supports FB-aided tracheal intubation. • If SGA rescue has occurred, then patient awakening is preferred: if not feasible, other options include FB-aided intubation through the SGA, or FONA during SGA-supported ventilation. Proceed with surgery only if considered safe. • Above all, the safety of the team must be prioritized. | |
• Scalpel-bougie emergency FONA is the recommend technique. • Transiently discontinue attempted FMV or SGA ventilation during incision of cricothyroid membrane. | |
• Avoid awake intubation unless high risk of a CVCO situation with induction of general anesthesia/RSI. • VL or flexible bronchoscopy can be used for awake tracheal intubation, skills allowing. Consider use of an SGA as a conduit for the FB. • Consider alternatives to local anesthetic nebulization or aerosolization for topical airway anesthesia, e.g., local anesthetic gels/ointments or nerve blocks. | |
• Avoid circuit disconnections. • Place ventilator into standby mode if disconnection is needed. • Disconnect circuit proximal to viral filter if feasible; if not, then consider temporarily clamping the tracheal tube, seeking to avoid damaging it or its pilot line. | |
• Tracheal extubation is an AGMP with potentially higher risk for aerosol generation than intubation • Use pharmacologic measures to help prevent cough, agitation, or vomiting during or after extubation. • Place a surgical or procedure mask on the patient • Avoid airway exchange procedures if possible. | |
• Dispose of airway management equipment appropriately. • Doff PPE | |
AGMP = aerosol-generating medical procedure; CAFG = Canadian Airway Focus Group; CVCO = cannot ventilate, cannot oxygenate; eFONA = emergency front of neck airway access; FB = flexible bronchoscope; FMV = face-mask ventilation; FONA = front of neck airway access; NMB = neuromuscular blockade; PEEP = positive end-expiratory pressure; PPE = personal protective equipment; RSI = rapid-sequence intubation; SGA = supraglottic airway.
Fig. 2Considerations for planning for safe tracheal extubation.
Potential causes of an at-risk extubation
• Functional airway obstruction and/or inadequate management of secretions, due to: ○ Skeletal muscle weakness from residual neuromuscular blockade or intrinsic neuromuscular disease ○ Pre-existing obesity or OSA combined with opioids, residual anesthetics, or other sedative agents ○ Impaired neurologic status or excess drowsiness. • Anatomic airway obstruction from: ○ Airway edema, due to: ▪ Prolonged prone or Trendelenburg intraoperative positioning; ▪ Known traumatic or multiple attempts at tracheal intubation; ▪ Administration of large volumes of crystalloid fluid; ▪ Residual edema after tracheal intubation for neck hematoma or airway infection; ▪ In ICU patients, prolonged intubation, large tracheal tube diameter, female sex, unplanned extubation; ▪ Pre-existing edema (e.g., burns or neck radiation). ○ Extrinsic airway compression, e.g., due to neck hematoma, mediastinal mass ○ Airway obstruction from secretions or blood ○ Tracheal collapse, (e.g., tracheomalacia after goitre excision or prolonged intubation) ○ Laryngospasm ○ Unilateral or bilateral vocal cord paresis or paralysis ○ Cervical spine pre-vertebral swelling ○ Surgical occipital-cervical fixation in excess flexion ○ Multi-level cervical spine fusion • Cardiopulmonary issues (especially in ICU): ○ Respiratory failure due to non-resolution of an underlying problem ○ Compromised functional residual capacity from obesity, gastric distension with air, incisional pain, or other reason ○ Atelectasis; pneumothorax ○ Advanced chronic obstructive pulmonary disease ○ Left or right ventricular dysfunction ○ Fluid overload. • Other perioperative issues including hypothermia, altered acid-base status and uncontrolled pain. |
• The original tracheal intubation was difficult. • Interval development of airway edema. • Anatomic changes as a result of a surgical intervention: ○ Upper airway surgery ○ Upper cervical spine fusion. • Applied mechanical constraints, including: ○ Intermaxillary fixation ○ Halo jacket. |
ICU = intensive care unit; OSA = obstructive sleep apnea.
Strategies to address the at-risk patient upon tracheal extubation
• At risk of functional airway obstruction: ○ Plan a multi-modal analgesia strategy for a surgical patient to help minimize need for opioids. ○ Consider continuation of ventilation in the short- or medium-term to allow full recovery from inhaled or intravenous anesthetic or sedative agents. ○ Ensure recovery from neuromuscular blocking agents quantitatively; non-depolarizing agents should have recovery to a train of four ≥ 0.9 before extubation. ○ Tracheal extubation awake, rather than deep. ○ Extubation in a head-up or back up position. ○ Early transition to CPAP mask, NIV • At risk of airway edema: ○ Consider more objective assessment of the degree of edema by use of a cuff leak test and/or indirect visualization of pharynx and larynx with VL or flexible endoscopy. ○ Consider deferral of extubation pending a period of short- or medium-term ventilation with head-up positioning and/or administration of steroids. • Optimize cardiac, pulmonary, neurologic, acid-base and body temperature status. • Consider whether elective tracheotomy might offer a higher margin of safety. |
• Extubate only with a team briefing regarding the plan for re-intubation if needed. • Consider deferral of extubation until patient condition is optimized, location is optimal, and equipment and skilled personnel are available for re-intubation if required. • Consider extubation over a place-holder airway exchange catheter (see narrative). • Consider whether elective surgical airway might offer a higher margin of safety. |
CPAP = continuous positive airway pressure; HFNO = high-flow nasal oxygenation; NIV = non-invasive ventilation; VL = video laryngoscopy.
Potential human factor issues during patient evaluation and airway management decision-making, with suggested mitigation strategies
• Review your planned strategy for a high-risk or difficult case with a colleague. • With predicted difficulty, before proceeding, ensure that all equipment for your airway strategy (i.e., planned primary and fallback techniques) is physically present, sized for the patient, and arranged in the order of anticipated use. This well help ensure you have thought through the situation. | • For all patients, brief the team on your chosen strategy, including your alternate plans if the intended technique fails, together with triggers for moving to an alternate plan. • During the briefing, specifically empower team members to speak up if they think that a trigger has occurred. | • The organization should mandate inclusion of the airway strategy in the first surgical safety checklist. • Airway management education programs should include material on safe decision-making, rather than only teaching “hands-on” skills. | |
• Enlist a colleague to help perform ATI: you will both benefit from the experience. • Seek opportunities to perform ATIs, rather than using excuses to avoid them. • If the patient’s anatomy is amenable, consider using a more familiar device for ATI (e.g., VL). | • For the patient requiring ATI with obstructing pathology, a surgeon should be physically present to perform fallback eFONA. | • The organization should provide training and maintenance of competence workshops in ATI techniques, including use of the FB. • Provide airway simulators or standard airway training manikins for individual practice at any time. • Ensure equipment for all aspects of ATI is easily accessible at airway management locations. • Package all equipment and local anesthetics needed for topical airway anesthesia together in easily-accessed “grab kits”. | |
| “ | • When sensing production pressure, (whether self-induced or from another source) push back by deliberately slowing to reflect on whether the pressure is adversely impacting your patient’s safety. • Pre-empt any pushback on planned ATI by using “safest for the patient” language. | • Increase team buy-in by early communication with the surgeon and team when ATI is needed for an operative case. | • Multidisciplinary team training or rounds on adverse airway events might help improve communication and cooperation for future difficult airway situations that involve multiple specialties. |
• With significant predicted difficulty, if considering tracheal intubation after the induction of general anesthesia, as a thought exercise, satisfy yourself that it can occur with a margin of safety equal to or greater than ATI. If not, proceed with the ATI. • Beware of “gambler’s fallacy”: the false belief that the outcome of the current case is less (or more) likely given results of previous events. Judge every case on its own, based on findings from the airway evaluation. | • Team members should be encouraged to speak up if uncomfortable with the airway manager’s chosen approach. The “PACE” (probe-alert-challenge-emergency) or similar mnemonic can be used as a prompt by team members to question the planned approach. | • Appoint a hospital “airway lead” | |
ATI = awake tracheal intubation; eFONA = emergency front of neck airway access; FB = flexible bronchoscope; VL = video laryngoscopy.
| Contributions | Disclosure(s) | |
|---|---|---|
| J. Adam Law, MD | Focus Group chair; data acquisition, analysis and interpretation; writing and critically revising article; final approval of version to be published. | Work supported by the Department of Anesthesia, Dalhousie University. Course co-director of Recipient of equipment as loan or donation from Verathon, Ambu, Karl Storz and Covidien. |
| Laura Duggan, MD | Data acquisition, analysis and interpretation; critically revising article; final approval of version to be published. | Editor of the journal |
| Mathieu Asselin, MD | Data acquisition, analysis and interpretation; writing and critically revising article; final approval of version to be published. | None |
| Paul Baker, MBChB, MD | Data acquisition, analysis and interpretation; critically revising article; final approval of version to be published. | Co-owner and inventor, the ORSIM bronchoscopy simulator. Owner of the AirwaySkills course and recipient of equipment as loan or donation from Fisher and Paykel Healthcare, Karl Storz, Verathon, Ambu, Covidien, Truphatec, AAM Healthcare, Welch Allyn |
| Edward Crosby, MD | Data acquisition, analysis and interpretation; writing and critically revising article; final approval of version to be published. | None |
| Andrew Downey, MBBS | Data acquisition, analysis and interpretation; critically revising article; final approval of version to be published. | None |
| Orlando R. Hung, MD | Data acquisition, analysis and interpretation; critically revising article; final approval of version to be published. | Holds a US patent of a Light-guided Tracheal Intubation Device. Co-authored a textbook: |
| Philip M. Jones, MD, MSc | Data acquisition, analysis and interpretation; critically revising article; final approval of version to be published. | No industry conflicts to declare. Dr Jones is Deputy Editor-in-Chief of the |
| George Kovacs, MD, MHPE | Data acquisition, analysis and interpretation; critically revising article; final approval of version to be published. | Work supported by the Department of Emergency Medicine, Dalhousie University. Course co-director of |
| François Lemay, MD | Data acquisition, analysis and interpretation; critically revising article; final approval of version to be published. | None |
| Rudiger Noppens, MD PhD | Data acquisition, analysis and interpretation; critically revising article; final approval of version to be published. | Recipient of equipment for clinical trial from Karl Storz, Germany. Recipient of honoraria from Medtronic and Karl Storz for lectures at Euroanesthesia. |
| Matteo Parotto, MD, PhD | Data acquisition, analysis and interpretation; writing and critically revising article; final approval of version to be published. | Supported by an Early Investigator Award from the Department of Anesthesiology and Pain Medicine, University of Toronto and Toronto General Hospital |
| Roanne Preston, MD | Data acquisition, analysis and interpretation; critically revising article; final approval of version to be published. | None |
| Nick Sowers, MD | Data acquisition, analysis and interpretation; critically revising article; final approval of version to be published. | None |
| Kathryn Sparrow, MD, MScHQ | Data acquisition, analysis and interpretation; writing and critically revising article; final approval of version to be published. | Received one prior honorarium for attending an expert input forum from Merck Canada Inc. As an instructor and course faculty member, she has received honoraria from Airway Interventions and Management in Emergencies (AIME), The Difficult Airway Course, and Heart and Stroke Foundation of Canada. |
| Timothy P. Turkstra, MD, MEng | Data acquisition, analysis and interpretation; writing and critically revising article; final approval of version to be published. | None |
| David T. Wong, MD | Data acquisition, analysis and interpretation; critically revising article; final approval of version to be published. | Board of Directors, Society for Airway Management |